| Product Code: ETC10602414 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Ireland continued to import Human Papilloma Virus products mainly from the USA, UK, Germany, Metropolitan France, and Serbia. The market showed a high concentration with the Herfindahl-Hirschman Index (HHI) remaining elevated. However, the compound annual growth rate (CAGR) from 2020 to 2024 was negative at -4.18%, indicating a challenging market environment. The growth rate dropped significantly from 2023 to 2024 by -30.16%, suggesting a potential decline in demand or other market factors affecting the import of HPV-related products into Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Human Papilloma Virus Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Human Papilloma Virus Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Human Papilloma Virus Market - Industry Life Cycle |
3.4 Ireland Human Papilloma Virus Market - Porter's Five Forces |
3.5 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Virus Type, 2022 & 2032F |
3.6 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Vaccine Type, 2022 & 2032F |
3.7 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Application Area, 2022 & 2032F |
3.8 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Target Population, 2022 & 2032F |
3.9 Ireland Human Papilloma Virus Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Ireland Human Papilloma Virus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination for preventing HPV-related diseases |
4.2.2 Government initiatives to promote HPV vaccination programs |
4.2.3 Growing prevalence of HPV infections and related diseases in Ireland |
4.3 Market Restraints |
4.3.1 High cost associated with HPV vaccines and screening tests |
4.3.2 Limited access to healthcare services in certain regions of Ireland |
4.3.3 Stigma and misconceptions surrounding HPV vaccination |
5 Ireland Human Papilloma Virus Market Trends |
6 Ireland Human Papilloma Virus Market, By Types |
6.1 Ireland Human Papilloma Virus Market, By Virus Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Virus Type, 2022 - 2032F |
6.1.3 Ireland Human Papilloma Virus Market Revenues & Volume, By HPV 16 & 18, 2022 - 2032F |
6.1.4 Ireland Human Papilloma Virus Market Revenues & Volume, By Low-Risk HPV Strains, 2022 - 2032F |
6.2 Ireland Human Papilloma Virus Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccine, 2022 - 2032F |
6.2.3 Ireland Human Papilloma Virus Market Revenues & Volume, By Therapeutic Vaccine, 2022 - 2032F |
6.3 Ireland Human Papilloma Virus Market, By Application Area |
6.3.1 Overview and Analysis |
6.3.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccination, 2022 - 2032F |
6.3.3 Ireland Human Papilloma Virus Market Revenues & Volume, By Cancer Prevention, 2022 - 2032F |
6.4 Ireland Human Papilloma Virus Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Teenagers, Young Adults, 2022 - 2032F |
6.4.3 Ireland Human Papilloma Virus Market Revenues & Volume, By High-Risk Individuals, 2022 - 2032F |
6.5 Ireland Human Papilloma Virus Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Cervical Cancer Prevention, 2022 - 2032F |
6.5.3 Ireland Human Papilloma Virus Market Revenues & Volume, By Oncology Care, 2022 - 2032F |
7 Ireland Human Papilloma Virus Market Import-Export Trade Statistics |
7.1 Ireland Human Papilloma Virus Market Export to Major Countries |
7.2 Ireland Human Papilloma Virus Market Imports from Major Countries |
8 Ireland Human Papilloma Virus Market Key Performance Indicators |
8.1 Number of individuals vaccinated against HPV |
8.2 Rate of HPV-related diseases in Ireland |
8.3 Percentage of healthcare professionals recommending HPV vaccination |
8.4 Level of government funding allocated to HPV vaccination programs |
8.5 Public awareness and knowledge about HPV and its prevention |
9 Ireland Human Papilloma Virus Market - Opportunity Assessment |
9.1 Ireland Human Papilloma Virus Market Opportunity Assessment, By Virus Type, 2022 & 2032F |
9.2 Ireland Human Papilloma Virus Market Opportunity Assessment, By Vaccine Type, 2022 & 2032F |
9.3 Ireland Human Papilloma Virus Market Opportunity Assessment, By Application Area, 2022 & 2032F |
9.4 Ireland Human Papilloma Virus Market Opportunity Assessment, By Target Population, 2022 & 2032F |
9.5 Ireland Human Papilloma Virus Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 Ireland Human Papilloma Virus Market - Competitive Landscape |
10.1 Ireland Human Papilloma Virus Market Revenue Share, By Companies, 2025 |
10.2 Ireland Human Papilloma Virus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here